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Abstract: High-definition optical coherence tomography (HD-OCT) 
features of basal cell carcinoma (BCC) have recently been defined. We 
assessed in vivo optical properties (IV-OP) of BCC, by HD-OCT. 
Moreover their critical values for BCC subtype differentiation were 
determined. The technique of semi-log plot whereby an exponential 
function becomes linear has been implemented on HD-OCT signals. The 
relative attenuation factor (µraf) at different skin layers could be assessed.. 
IV-OP of superficial BCC with high diagnostic accuracy (DA) and high 
negative predictive values (NPV) were (i) decreased µraf in lower part of 
epidermis and (ii) increased epidermal thickness (E-T). IV-OP of nodular 
BCC with good to high DA and NPV were (i) less negative µraf in papillary 
dermis compared to normal adjacent skin and (ii) significantly decreased E-
T and papillary dermal thickness (PD-T). In infiltrative BCC (i) high µraf in 
reticular dermis compared to normal adjacent skin and (ii) presence of 
peaks and falls in reticular dermis had good DA and high NPV. HD-OCT 
seems to enable the combination of in vivo morphological analysis of 
cellular and 3-D micro-architectural structures with IV-OP analysis of 
BCC. This permits BCC sub-differentiation with higher accuracy than in 
vivo HD-OCT analysis of morphology alone. 
© 2016 Optical Society of America 
OCIS codes: (170.4500) Optical coherence tomography; (170.1870) Dermatology; (170.3660) 
Light propagation in tissues; (170.6935) Tissue characterization; (170.7050) Turbid media; 
(290.0290) Scattering. 
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1. Introduction 
Basal cell carcinoma (BCC) is the most prevalent skin cancer among Caucasians [1,2]. The 
incidence of BCC continues to increase worldwide. As a consequence, BCC treatment is 
associated with relevant health costs for the society. It is a multifactorial disease in which 
excessive sun exposure plays a major pathogenic role [3,4]. 
Treatment strategy has changed in the last two decades [5]. With the emergence of non-
invasive therapies for superficial BCC (sBCC) such as topical immunotherapies and 
photodynamic therapy, there is an urgent demand for real time non-invasive diagnosis and 
monitoring [6–9]. 
Nowadays, a broad variety of imaging techniques are becoming available. Dermoscopy is 
very useful for the clinical diagnosis of BCC [10–15]. In the past decade other non-invasive 
techniques including reflectance confocal microscopy (RCM) [16–21], conventional optical 
coherence tomography (C-OCT) [22–27] and multiphoton tomography (MPT) [28] have 
become available for the in-vivo diagnosis of BCC. Of these, RCM in the hands of an expert 
has shown high diagnostic accuracy for the diagnosis of BCC, with a sensitivity of 100% and 
a specificity of 85% in a large multicenter study [19]. The diagnostic accuracy of MPT still 
needs to be determined [28]. The diagnostic accuracy of C-OCT has been evaluated in large 
multicenter studies [25–28]. 
High-definition optical coherence tomography (HD-OCT) is a recently introduced non-
invasive real-time 3-D imaging technique with cellular resolution, which may aid in BCC 
diagnosis and managing [29–32]. Based on 3-D HD-OCT features of BCC a diagnostic 
algorithm is proposed permitting discrimination of BCC from clinical BCC imitators and 
differentiation of BCC subtypes [33]. Additionally, a testing set has been performed [34] to 
assess the diagnostic performance of this algorithm. The diagnostic accuracy of each 
observer was clearly associated with the level of experience, which suggests the existence of 
a learning curve. 
New diagnostic tools providing automated classification of skin lesions usable by non-
experts, have been proposed [35,36]. Spectral methods fall into this class of emerging new 
techniques holding the promise to improve early diagnosis of skin cancer [36,37]. In two 
recent studies we demonstrated that HD-OCT permits to quantify in vivo optical properties 
(IV-OP) such as light attenuation in intrinsic ageing skin [38] and in melanocytic lesions 
[39]. This approach seems to permit a semi-automated classification of skin lesions easier to 
handle by non-experts. 
Therefore the aim of this paper was to quantify IV-OP of BCC, such as light attenuation, 
by means of HD-OCT in comparison with normal adjacent skin. An additional objective was 
to determine the best critical value of these optical properties for BCC subtype 
discrimination. 
2. Methods 
2.1 Study sample 
This retrospective pilot study included HD-OCT images of sBCC, nodular BCC (nBCC) and 
infiltrative BCC (iBCC) consecutively retrieved at first author’s private practice between 
January 2011 and November 2015. HD-OCT images of the healthy skin adjacent to each 
BCC were also taken and used as control. Inclusion criteria were: (i) confirmed 
histopathological diagnosis of BCC subtype and (ii) availability of good quality HD-OCT 
images. 
All patients provided informed consent for imaging their lesion by HD-OCT (Skintell, 
Agfa Healthcare, Mortsel, Belgium). We conformed to the Helsinki Declaration with respect 
to human subjects in biomedical research. All international rules governing clinical 
investigation of human subjects were strictly followed. Approval from local ethical 
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committee was obtained (P2015-389). Moreover this study affected neither the routine 
diagnosis nor treatment of the lesions presented by the included subjects. 
2.2 Histopathology 
In the present study, all lesions were fully excised and examined histopathologically for 
diagnostic confirmation. Histopathological analysis was carried out by two board-certified 
histopathologists. 
2.3 Image acquisition by HD-OCT 
Instruments and acquisition methods and technical details have been previously described 
[40–42]. For the purpose of this study we will remind that HD-OCT offers a constant 
homogeneous resolution of 3 µm in all three dimensions. The system is capable of capturing 
a cross-sectional and en face image in real time, with a fast real time 3-D acquisition. A sharp 
image at all depth is guaranteed up to a depth of 570 µm. The field of view is 1.8 x 1.5 mm. 
The total light power at the tissue is < 3.5 mW. 
2.4 HD-OCT focus tracking permits IV-OP analysis 
Skin is a highly turbid medium. Light that propagates through skin is scattered and absorbed 
resulting in its attenuation. In contradiction to a “normal” light detector, HD-OCT only 
detects photons which reach the detector on an almost straight path – the ballistic portion of 
the photons or photons which were only forward scattered a few times [43]. 
Table 1. Parameters (abbreviation and definition) used in this study 
Abbreviation Definition 
SE-S Skin entrance (SE) signal. OCT signal (arbitrary unit, a.u.) at SE. Corresponds to the first 
bright band (first peak: FP) on cross-sectional imaging (Fig. 1). 
DEJ-S Dermo-epidermal junction (DEJ) signal. OCT signal (a.u.) at DEJ. DEJ corresponds to a 
dark band under the epidermis (valley: V) on cross-sectional imaging (Fig. 1). 
PRDJ-S Papillary-reticular dermis junction (PRDJ) signal. OCT signal (a.u.) at PRDJ. Corresponds 
to the second peak (SP) after the valley (Fig. 1). 
Layer-1 Epidermal layer: from SE (first peak) to DEJ (valley) 
Layer-2 Papillary dermal layer: from DEJ (valley) to PRDJ (second peak) 
Layer-3 Superficial reticular dermal layer: from PRDJ up to a depth of 570µm (theoretical 
penetration depth of HD-OCT). 
E-T Difference (µm) in Z-values (depth) between FP and V. This corresponds approximately to 
the epidermal thickness (E-T) if DEJ is very thin [38] 
PD-T Difference (µm) in Z-values (depth) between V and SP. This corresponds approximately to 
the papillary dermis thickness (PD-T) if DEJ is very thin [38]. 
Nod Corresponds to a specific Z-value within a layer where the slope of the curve changes, 
dividing the layer into two sublayers. 
Nod-L1 Presence of nod in semi-log plot in layer-1 dividing the epidermis in upper part (1a) and 
deeper part (1b). If the epidermal thickness of a BCC is lesser than the thickness of 
corresponding normal adjacent epidermis, absence of Nod-L1 will be assumed. 
Nod-L3 Presence of nod in semi-log plot in layer-3 dividing the superficial reticular dermis in 
upper part (3a) and deeper part (3b). 
P&F-L3 (nume-
rical variable =  
per lesion) 
This corresponds to the number of small increases of backscattering (peak) immediately 
followed by a decrease of backscattering (fall), disturbing the semi-log plot in layer 3, 
count up in a single BCC lesion or adjacent normal skin. 
P&F-L3am (mean = 
 ( per 
lesion)/16) 
The arithmetic mean of P&F-L3 is calculated by adding up all numbers of P&Fs in a set of 
BCC subtypes or corresponding adjacent skin and dividing this sum by the number of BCC 
lesions (#16) or normal adjacent skin (#16) in that set. 
µraf1-3 Relative attenuation factor (µm−1). The calculated attenuation coefficients are not absolute. 
The SE-S is used as reference intensity. Hence “relative” refers to the attenuation 
coefficient normalized to skin entrance signal for each of the three layers. Negative values 
for µraf imply increased backscattering. 
µraf1a, µraf1b A nod is present in layer-1 dividing µraf1 in µraf1a (part above nod) and µraf1b (part under 
nod). If Nod-L1 is absent µraf1 is divided in µraf1a (µraf1 in upper ½ of the epidermis) and 
µraf1b (µraf1 in lower ½ of epidermal layer). 
µraf3a, µraf3b A nod is present in layer-3 dividing µraf3 in an upper part µraf3a and a deeper part µraf3b. 
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The resulting attenuation coefficient was estimated by Jacques and associates [44–46]. 
Since absorption is much smaller than scattering for tissues in the near infrared (NIR) 
spectrum, absorption can be neglected [47]. HD-OCT operates in the second diagnostic 
window of the NIR spectrum [38,39] and hence the main attenuation mechanism for HD-
OCT is scattering. Measuring tissue optical properties in vivo is only applicable to OCT 
when operating in focus-tracking mode which is the case for HD-OCT [44]. A table 
providing definitions and abbreviations of optical properties adapted from the literature [43–
51] and relevant for this manuscript was already published [39]. 
2.5 In vivo optically probing and relative attenuation factor 
The decay of reflectance (backscattered intensity) with imaging depth of ballistic photons is a 
process that can be well-modelled by an exponential relationship [44,50]. When operating in 
the NIR diagnostic window, absorption becomes negligible and the slope of the exponential 
attenuation is proportional to the reduced scattering coefficient µ’s [44,50]. Analysis of the 
exponential profile of light attenuation by semi-log plot (an exponential function becomes a 
straight line given by y = ax + b), can provide information on tissue scattering properties 
[44,50]. 
The procedure used in this study is illustrated in Fig. 1. A 3-D HD-OCT DICOM (digital 
imaging and communication in medicine) image of the lesion was selected. This DICOM file 
was then opened using LabView software. A rectangular region of interest (> 0.1 mm2) was 
chosen in the en face image in order to i) obtain a clear-cut sample of the lobular structures, 
ii) avoid mismatching between layers (if skin surface was obliquely with respect to the 
probe), and iii) exclude “artefacts” (wrinkles, follicles) from the sample. A plot z-axis profile 
of this region was performed. The obtained graph displayed the reflectance and attenuation of 
the ballistic photons (OCT-signal) which was measured on the y-axis with arbitral units (a.u.) 
versus imaging depth which is indicated on the x-axis (µm). The first peak corresponded with 
the skin entrance signal (SE-S). The distance from Z = 0 to the first peak was the thickness of 
the optical gel. 
In order to normalize the OCT signal, the offset corresponding with the mean signal 
within optical gel were removed from each OCT signal in a first step. In a second step, all 
these HD-OCT values were divided by SE-S in order to normalize them to the SE-S (see 
graph a3 in Figs. 1, 2, and 3). To measure the absolute attenuation coefficient it is necessary 
to have a measurement system with a perfectly linear behaviour. The numerical measurement 
values must be proportional to the light intensity. This calibration was not tested to the full 
extent with the Skintell. Hence, the SE-S was used as reference intensity as this signal is 
clearly defined. Moreover, absolute values of attenuation are not required as only differences 
in attenuation were taken into account. The natural logarithm ln(x) of those normalized 
values was taken (see graph a4 in Figs. 1, 2, and 3). An exponential function became linear 
described by y = ax + b (Semi-log plot) whereby coefficient a provided the relative 
attenuation factor µraf, which is the attenuation coefficient normalized to the SE-S. 
2.6 The following optical properties were measured (see Table 1 for abbreviations) 
The following OCT signals were measured at different selected Z-values: SE-S, DEJ-S, 
PRDJ-S (arbitrary unit, a.u.). The junction between PD and RD (PRDJ) is represented by the 
highest peak after the valley [38,51]. The thickness (µm) of epidermis and papillary dermis 
were calculated. Successive layers with clear exponential decay were identified and plotted: 
epidermis (layer-1), papillary dermis (layer-2) and superficial papillary dermis (layer-3). A 
straight line was fitted in each of the three layers (i = 1 to3) resulting in equation of the type 
yi = aixi + bi whereby coefficient a provided the relative attenuation factor for each of the 
three layers (µraf1-3; µm−1). The presence/absence of nods in semi-log plot (Nod-L1 and Nod-
#260406 Received 2 Mar 2016; revised 15 May 2016; accepted 15 May 2016; published 19 May 2016 
(C) 2016 OSA 1 June 2016 | Vol. 7, No. 6 | DOI:10.1364/BOE.7.002269 | BIOMEDICAL OPTICS EXPRESS 2274 
L3) were identified (Yes/No). Supplementary peaks and falls in third layer (P&F-L3) were 
evaluated. 
If a nod was present in layer-1, the relative attenuation factor µraf1 was subdivided in µraf1a 
and µraf1b. If Nod-L1 was absent µraf1 was divided in µraf1a (µraf1 in upper ½ of the epidermis) 
and µraf1b (µraf1 in lower ½ of epidermal layer). Negative values for µraf imply increased 
backscattering. 
2.7 Statistical analysis 
The paired T-test was used to compare lesioned to healthy adjacent skin. The unpaired (two-
sample) T-test was used to compare normal adjacent skin of the three BCC subtypes (NL-
sBCC, NL-nBCC and NL-iBCC). 
One-way analysis of variance (ANOVA) was used to compare means of three samples 
(sBCC, nBCC, iBCC) using the F distribution. Prior to the Anova test, Levene's Test for 
“equality of variances” was performed. If the Levene test was positive (P<0.05) then the 
variances in the different groups were different (the groups are not homogeneous) and a 
logarithmic transformation to the data has been performed. Moreover Scheffé test was used 
for all pairwise comparisons. 
The best critical value of all HD-OCT assessed optical properties was determined by 
applying the receiver operating characteristic (ROC) curves. This is a graph displaying the 
relationship between the true positive rate (on the vertical axis) and the false positive rate (on 
the horizontal axis). 
Based on these critical values absolute and relative frequencies were calculated for the 
three subgroups. Chi-squared (X2) test was employed to compare subgroups. The phi (φ) 
coefficient, employed to weight diagnostic power of each significant parameter, is a measure 
of association of two binary variables and is related to the chi-squared (X2) statistic by the 
formula: φ2 = X2/n, where n equals the total number of observations. Calculations were made 
by using MedCalc statistical software version 14.12.0. 
3. Results 
3.1 Subjects 
We included in this study 48 cases comprising 16 sBCC, 16 nBCC and 16 iBCC. All sBCC 
were located on the trunk. All nBCC and iBCC were located on the face, except for 1 nBCC 
and 2 iBCC with truncal localization. The study lesions belonged to 28 females and 20 males 
with skin type I-III and ages ranging from 45 to 84 years (median 61 years). The healthy skin 
adjacent to each of the 48 included BCC was also imaged (16 NL-sBCC, 16 NL-nBCC and 
16 NL-iBCC). 
3.2 Quantitative IV-OP analysis (Table 2) 
3.2.1 Comparison between trunk and facial skin. NL-sBCC (predominantly trunk) versus NL-
nBCC and NL-iBCC (predominantly face) (p-values in columns 3, 6 and 9 respectively) 
Normal skin adjacent to sBCC (NL-sBCC) presented significant differences (p<0.01) 
regarding SE-S, PRDJ-S, E-T, PD-T, µraf1a, µraf2, µraf3a, µraf3b in comparison with normal skin 
adjacent to nBCC (NL-nBCC) and iBCC (NL-iBCC). No significant differences were 
observed between NL-nBCC and NL-iBCC except for µraf3b. A significant difference 
(p<0.01) regarding µraf3b was observed between the three subgroups. 
3.2.2 Comparison between BCC subtype (sBCC, nBCC and iBCC) and corresponding 
normal adjacent skin (p-values in columns 4,7 and 10 respectively) 
Compared to NL-sBCC, sBCC presented significant differences (p<0.001) regarding SE-S, 
DEJ-S, PRDJ-S, E-T, µraf1b. Compared to NL-nBCC, nBCC presented significant differences 
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(p<0.001) regarding E-T and PD-T. Moreover in nBCC no NOD-L1, higher P&F-L3, lower 
µraf1a, higher µraf1b were detected (p<0.01) compared to NL-nBCC. A less negative µraf2 
compared to NL-nBCC was only (p<0.01) observed in nBCC. Compared to NL-iBCC, iBCC 
presented significant differences (p<0.01) regarding DEJ-S, PRDJ-S, E-T and PD-T. 
Moreover compared to NL-iBCC, iBCC presented no NOD-L1, higher P&F-L3, lower µraf1a 
and higher µraf1b. A significant increase (p<0.01) of µraf3b compared to normal adjacent skin 
was only observed in iBCC and not in the other BCC subgroups. 
3.2.3 Comparison between BCC subtypes (Figs. 1, 2, and 3) (p-values in columns 2, 5 and 8 
respectively) 
No significant difference could be observed between the three subgroups about SE-S and 
µraf1a. A significant (p<0.005) difference could be observed between sBCC and the other two 
groups concerning DEJ-S, PDRJ-S, presence of NOD-L, µraf2 and µraf3a,. A significant 
difference (p<0.001) in E-T, PD-T and P&F-L3, µraf1b and µraf3b could be detected between 
the three subgroups. 
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 Fig. 1. Superficial BCC. (a) A 3-D HD-OCT DICOM (digital imaging and communication in 
medicine) image of the lesion is selected: en face image (a1) and cross-sectional image (a2). 
This DICOM file is then opened using LabView software. A region of interest (ROI) (> 0.1 
mm2) is chosen in the en face image (red square). In a first step, a plot z-axis profile of the 
scanned volume (> 0.05 mm3) is performed. The obtained graph (a3) displays the reflectance 
and attenuation of the ballistic photons (OCT-signal: measured on the y-axis with arbitral 
units (a.u.)) versus imaging depth which is indicated on the x-axis (µm). The distance from Z 
= 0 to the first peak is the thickness of the gel. The first peak at about 120 µm corresponds to 
the skin entrance signal (SE-S). The valley is noticed 352 µm deeper than the first peak. 
Consequently, the epidermis is approximately 232 µm thick in this ROI. The second peak is 
situated 50 µm deeper than the valley. Hence, the papillary dermis is approximately 50 µm 
thick in this ROI. In a second step, The HD-OCT signals were divided by SE-S in order to 
normalize them to the SE-S The natural logarithm ln(x) of those values is taken (a4). A semi-
log plot is performed; an exponential function becomes linear described by y = ax + b. 
Successive layers with clear exponential decay are identified and plotted. A straight line is 
fitted in each of these layers resulting in equation of type yi = axi + b whereby coefficient a 
provides the relative attenuation factor for each of the identified layers “i” given by µrafi. Data 
are summarized in table (a5): OCT signal at different Z-values (a.u.), distance (µm) between 
different Z values (vertical coloured lines) and µraf in different layers (1/µm). (b) high-
resolution en face images at different Z-values. Yellow arrows indicate the position of cross-
sectional images (c). Magenta arrows indicate the position of the en face images. Green 
arrows indicate the sBCC hemi-lobules. Optical properties of sBCC with high diagnostic 
accuracy (>95%) and high negative predictive values (NPV) (>97.5%) are the presence of a 
nod in semi-log plot of layer-1, much lower relative attenuation factor in lower part of 
epidermal layer (µraf1b) and strongly increased E-T. 
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Table 2. Quantitative evaluation of relevant parameters observed in basal cell 
carcinoma subtypes in comparison with normal adjacent skin. 
 
OPTICAL 
PROPERTIES 
sBCC NL-sBCC 
Trunk 
16/16 
Δ sBCC 
versus 
NL-
sBCC 
nBCC NL-nBCC 
Face 15/16 
Trunk 1/16 
Δ nBCC 
versus 
NL-
nBCC 
iBCC NL-iBCC 
Face 14/16 
Trunk 2/16 
Δ iBCC 
versus 
NL-iBCC
SE-S  
(a.u.) 
465.87  
[+/-87.66] 
NS 
362.93  
[+/- 66.25] 
(p<0.01)
p<0.001 552.72  
[+/-121.69] 
NS
539.19  
[+/- 111] 
NS
NS 578.40  
[+/-104.00] 
NS 
549.57  
[+/- 68.32] 
NS
NS 
DEJ-S (a.u.) 50.98  
[+/- 16.89] 
(p<0.001) 
97.61  
[+/- 19.87] 
NS 
p<0.001 256.12  
[+/- 77.91] 
NS 
179.17  
[+/- 100.33] 
NS
NS 186.40  
[+/- 22.30] 
NS 
132.48  
[+/- 18.95] 
NS
p<0.001 
PRDJ-S (a.u.) 73.86  
[+/- 19.13] 
(p<0.001) 
143.6  
[+/- 35.61] 
(p<0.01)
p<0.001 367.49  
[+/-93.77] 
NS
289.36  
[+/-61.68] 
NS
NS 357.93  
[+/- 78.62] 
NS 
266.81  
[+/- 44.89] 
NS
p<0.01 
 
E-T 
(µm) 
188.25  
[+/-39.12] 
(p<0.001) 
84.61  
[+/- 9.96] 
(p<0.01)
p<0.001 25.81  
[+/-4.29] 
(p<0.001) 
54.38  
[+/- 8.99] 
NS
p<0.0001 43.25  
[+/-7.59] 
(p<0.001) 
63.60  
[+/- 7.12] 
NS
p<0.0001 
PD-T 
(µm) 
49.81  
[+/-7.85] 
(p<0.001) 
42.49  
[+/- 6.74] 
(p<0.01)
NS 16.87  
[+/-2.52] 
(p<0.0001)
25.53  
[+/- 4.44] 
NS
p<0.001 25.62  
[+/-1.62] 
(p<0.001) 
33.26  
[+/-5.91] 
NS
p<0.01 
NOD-L1 16/16 
(p<0.001) 
16/16 
NS 
NS 0/16 
NS 
16/16 
NS
P<0.001 0/16 
NS 
16/16 
NS
p<0.001 
NOD-L3 16/16 
NS 
16/16 
NS 
NS 16/16 
NS
16/16 
NS
NS 16/16 
NS 
16/16 
NS
NS 
P&F-L3am 
(∑ of ∑ per 
lesion) / 16 
0.25  
[+/- 0.28] 
(p<0.001) 
0.68  
[+/- 0.37] 
NS 
NS 1.43  
[+/- 0.61] 
(p<0.001)
0.31  
[+/- 0.26] 
NS
p<0.01 2.87  
[+/-0.73] 
(p<0.001) 
0.31  
[+/- 0.26] 
NS
p<0.0001 
 µraf1a  
(µm-1) 
0.02781  
[+/-0.0098] 
NS 
0.02692  
[+/-
0.0069] 
(p<0.01)
NS 0.0410  
[+/-0.0098] 
NS 
0.0579  
[+/- 0.0117] 
NS 
P<0.01 0.0265  
[+/-0.0053] 
NS 
0.0461  
[+/-0.0090] 
NS 
p<0.01 
 µraf1b  
(µm-1) 
0.0101 
[+/-0.0015] 
(p<0.001) 
0.0146  
[+/- 
0.0008] 
NS 
p<0.001 0.0410 
[+/-0.0098] 
(p<0.001) 
0.0156  
[+/- 0.0052] 
NS 
p<0.001 0.0265  
[+/-0.0053] 
 (p<0.001) 
0.0180  
[+/-0.0031] 
NS 
p<0.01 
 µraf2  
(µm-1) 
-0.0114  
[+/- 
0.0029] 
(p<0.005) 
-0.0119  
[+/-  
0.0032] 
(p<0.01)
NS -0.0226  
[+/-  
0.0079] 
NS
-0.0468  
[+/-  
0.0107] 
NS
P<0.01 -0.0380  
[+/- 
 0.0097] 
NS 
-0.0393 
[+/-  
0.0118] 
NS
NS 
 µraf3a  
(µm-1) 
0.0135  
[+/-0.0017] 
(p<0.001) 
0.0153  
[+/-
0.0032] 
(p<0.01)
NS 0.0360  
[+/-0.0128] 
NS 
0.0243  
[+/- 0.0030] 
NS 
NS 0.0235  
[+/-0.0044] 
NS 
0.0266  
[+/-0.0049] 
NS 
NS 
µraf3b  
(µm-1) 
0.0119  
[+/-0.0017] 
 (p<0.001) 
0.0147 
[+/-
0.0024] 
(p<0.01)
NS 0.0076  
[+/- 0.0009] 
 (p<0.001) 
0.0067  
[+/- 0.0002] 
(p<0.01) 
NS 0.0229  
[+/- 0.0044] 
(p<0.001) 
0.0121 [+/- 
0.0021] 
(p<0.01) 
p<0.01 
Values given are mean values and 95% confidence interval. The p-values (in bold) in columns 2, 5 and 8: tested p-values between the respective 
BCC subtypes; in columns 3, 6 and 9: tested p-values between the respective adjacent normal skins of sBCC, nBCC and iBCC; in columns 4, 7 and 
10: tested p-values of difference between each BCC subtype and their respective adjacent normal skin. NS: not significant.  
3.3 Selection of best critical value of IV-OP 
Critical values permitting differentiation of the three subgroups could be defined by applying 
the ROC curves (Table 3). 
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Table 3. Selection of best critical value of relevant optical properties of basal cell 
carcinoma subtypes by applying receiver operating characteristic curves. 
Optical properties Critical 
value 
Area 
under 
ROC 
curve 
Sensitivity Specificity Accuracy Positive 
likelihood 
ratio 
DIFFERENTIATING SUPERFICIAL BCC FROM OTHER SUBTYPES 
E-T (µm) >69 0.998 100% 96.87% 97.9% 32 
Presence NOD-
L1 
Yes 1 100% 100% 100%  
Relative 
attenuation factor 
layer1b (µm−1) 
<0.0172 0.928 100% 87% 91.7% 8 
DIFFERENTIATING NODULAR BCC FROM OTHER SUBTYPES 
PD-T (µm) < 23 0.981 93.8% 96.9% 95.83% 15 
Less negative µraf2 
compared to 
normal skin 
(µm−1)* 
Increase 
>0.0147 
0.940 87.5% 93.8% 91.7% 9.3 
DIFFERENTIATING INFILTRATIVE BCC FROM OTHER SUBTYPES 
Peaks&Falls-L3 
(mean) 
>1 0.861 87.5% 75% 79.17% 3.5 
Increased µraf3b 
(µm−1) compared 
to normal skin° 
>0.0051 0.940 93.8% 93.8% 93.8% 13 
* Δ nBCC- NL-nBCC: 0.024 µm−1 [+/− 0.0081] (p<0.01) compared to other subgroups. 
° Δ iBCC- NL-iBCC: 0.0114 µm−1 [+/− 0.0045] (p<0.01) compared to other subgroups. 
3.4 Absolute and relative frequencies of IV-OP in relation to best critical values (Table 4) 
3.4.1 Differentiation of sBCC from other BCC subtypes (Fig. 1) 
E-T >69 µm was highly sensitive and specific for sBCC (100% and 96.87% respectively; 
NPV = 100%, PPV = 94.1%, φ = 0.95 and X2 = 43.76, p<0.0001). The diagnostic accuracy 
was 97.9%. Nod-L1 was a very highly sensitive and specific feature for sBCC (both 100%). 
No nod in layer-1 could be observed in other BCC subtypes. The µraf1b <0.0172 cm−1 was 
highly sensitive and moderately specific for sBCC (100% and 87% respectively; NPV = 
100%, PPV = 80%, φ = 0.84 and X2 = 33.6, p<0.0001). The diagnostic accuracy was 91.7%. 
3.4.2 Differentiation of nBCC from other BCC subtypes (Fig. 2) 
PD-T <23 µm was highly sensitive and specific for nBCC (93.8% and 96.9% respectively; 
NPV = 96.88%, PPV = 93.75%, φ = 0.91 and X2 = 39.42, p<0.0001). The diagnostic 
accuracy was 95.83%. A less negative µraf2 (increase of > 0.0147 cm−1) compared to normal 
skin was highly sensitive and specific for nBCC (85.7% and 93.8% respectively; NPV = 
93.8%, PPV = 87.5%, φ = 0.81 and X2 = 31.69, p<0.001). The diagnostic accuracy was 
91.7%. 
3.4.3 Differentiation of iBCC from other BCC subtypes (Fig. 3) 
P&F-L3 was moderately sensitive and modestly specific for iBCC (87.5% and 75% 
respectively; NPV = 92.31%, PPV = 63.64%, φ = 0.59 and X2 = 16.78, p<0.0001). The 
diagnostic accuracy was 79.17%. An increase of µraf3b of >0.0051 cm−1 compared to normal 
skin was highly sensitive and specific for iBCC (both 93.8%; NPV = 96.8%, PPV = 88.2%, φ 
= 0.86, X2 = 35.7, p<0.001). The diagnostic accuracy was 93.8%. 
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4. Discussion 
The non-invasive diagnosis of BCC and its clinical/pathological sub-differentiation has 
recently become of great importance for the correct management of the disease [36]. With the 
emergence of non-invasive therapy for sBCC there is an urgent demand for non-invasive 
diagnosis. 
 
Fig. 2. Nodular BCC. (a-c). For details about arrows see Fig. 1. Optical properties of nBCC 
with moderate to high diagnostic accuracy (91.7% - 95.8%) and high NPV (93.8% - 97.0%) 
were strongly decreased epidermal - and papillary dermal thickness and less negative µraf2 
compared to normal skin. 
Two major problems occur with non-invasive imaging technologies in BCC. First, the 
diagnostic performance of these techniques varies with the user’s experience and would be 
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consequently poor for non-expert physicians. The second problem is related to their limited 
capability to differentiate BCC subtypes. The results of a previous study by our group [33] 
were in line with literature data approaching the same problem with other methodologies 
[20]. Indeed, the distinction of BCC subtypes by means of reflectance confocal microscopy is 
mainly based on the assessment of BCC tumour islands (presence of palisading) thanks to the 
higher resolution of that technique as compared to HD-OCT [20]. Conversely, the 
discrimination of BCC subtypes by means of dermoscopy is mainly based on the vascular 
pattern [13–15] along with the presence of large blue-grey ovoid nests [15]. HD-OCT 
approach needs to combine both tumour islands assessment and vessel organization, to reach 
a good discrimination between different BCC subtypes, with the added advantage to explore 
the skin in depth (up to 570 µm) [15]. This comprehensive examination of the skin in depth is 
crucial, as it allows the visualisation of stretching effect that the tumour islands exert on the 
stroma, a feature that was detected in 95% of nBCC and 100% of iBCC, but in none of the 
sBCCs of our previous series [33]. 
Table 4. Absolute and relative frequencies of relevant optical properties of BCC 
subtypes in relation to critical values as assessed in vivo by High-Definition Optical 
Coherence Tomography 
 SUPERFICAL 
BCC 
N = 16 
NODULAR 
BCC 
N = 16 
INFILTRATIVE 
BCC 
N = 16 
DIFFERENTIATING SUPERFICIAL BCC 
E-T > 69 µm 16 (100%) 
(p<0.0001) 
0 (0%) 1 (6.25%) 
Presence of nod in layer1 (Yes) 16 (100%) 
(p<0.0001) 
0 (0%) 0 (0%) 
Relative attenuation factor layer1b 
< 0.0172 (µm−1) 
16 (100%) 
(p<0.0001) 
1 (6.25%) 3 (18.75%) 
DIFFERENTIATING NODULAR BCC 
PD-T < 23 µm 0 (0%) 15 (93.75%) 
(p<0.0001) 
1 (6.25%) 
Less negative µraf2 compared to 
normal skin: increase with > 0.0147 
µm−1 
1 (6.25%) 14 (87.5%) 
(p<0.001) 
1 (6.25%) 
DIFFERENTIATING INFILTRATIVE BCC 
Supplementary peaks &falls in 
superficial reticular dermis >1 
1 (6.25%) 7 (43.75%) 
 
14 (87.5%) 
(p<0.001) 
> 0.0051 µm−1 increase of µraf3b 
compared to normal skin 
0 (0%) 2 (12.5%) 14 (87.5%) 
(p<0.001) 
*p-values have been added whenever appropriate; for details see result section 
Both problems could be tackled by the introduction of user-independent automated 
classification systems of skin lesions based on their optical properties, which could be 
achieved by other techniques, such as spectrophotometric technologies [35]. Recent 
developments in this field concerning the diagnosis of BCC include imaging modalities such 
as elastic scattering spectroscopy and spectrophotometric intra-cutaneous analysis [36]. 
HD-OCT permitted also the assessment of in vivo optical properties such as light 
attenuation in intrinsic ageing skin [38] and in melanocytic lesions [39]. This approach seems 
to permit a semi-automated classification of lesions which is easier to handle by non-experts. 
The technique of semi-log plot whereby an exponential function becomes linear described by 
y = ax + b has been implemented on HD-OCT signals coming from three successive skin 
layers (epidermis, papillary dermis and superficial reticular dermis). This permitted the in 
vivo measurement of OCT signals at specific imaging depth such as SE, DEJ and PRDJ. To 
measure an absolute attenuation coefficient it is necessary to a have a measurement system 
with a perfectly linear behavior. This was however not tested to the full extent with the used 
Skintell. The best compromise was to use the skin entrance signal as reference as this signal 
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is clearly defined. Moreover, absolute values of the attenuation are not required as only 
differences were taken into account. The relative attenuation factor (µraf), which is the 
attenuation coefficient normalized to skin entrance signal, was assessed in epidermis, 
papillary dermis and superficial reticular dermis. HD-OCT operates in the second diagnostic 
window of the NIR spectrum [38,39] and hence the main attenuation mechanism for HD-
OCT is scattering. It can be assumed therefore that µraf is proportional to the reduced 
scattering coefficient. The presence/absence of Nod-L1, Nod-L3 and P&F-L3 could be 
observed. 
 
Fig. 3. Infiltrative BCC. (a-c) For details see Fig. 1. Regarding the optical properties of iBCC 
an increase of µraf3b of >0.0051 cm-1 compared to normal skin and the presence of peaks and 
falls in reticular dermis had good diagnostic accuracy (79.1% - 93.8%) and high NPV (93.8% 
- 96.8%). 
Because the optical properties of human skin can vary significantly between individuals 
with different race, age and sun exposure, it is important to consider the difference in optical 
properties between lesioned skin and surrounding healthy skin region [44]. Critical optical 
properties were selected in a first step based on presence of significant differences between 
normal and lesioned skin. In a second step the differences regarding these properties among 
BCC subtypes were analyzed. 
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The sBCCs seems to be mainly located on the trunk where the UV-induced skin damage 
is less pronounced compared to the predominant facial localization of nBCCs and iBCCs, 
which are characterized by more intense sun-damage [15]. Intrinsic age and skin layer related 
values of µraf are displayed in Table 5 (unpublished data). The µraf1 in normal aged skin was 
in line with µraf1a of normal skin adjacent to BCC observed in this study. In papillary dermis 
of normal aged skin NIR light is backscattered even when solar elastosis is absent (µraf2 has a 
negative value). In normal skin adjacent to nBCC and iBCC light at papillary dermis is even 
more backscattered compared to intrinsic aged skin probably by the presence of solar 
elastosis. In the normal reticular dermis a Nod-L3 is observed dividing this layer in a 
superficial and deeper part. Normal µraf3a is not significant different according to age or 
anatomic site. However µraf3b decreases significantly with ageing suggesting an intrinsic 
ageing related increase in anisotropy of scattering in lower layers. 
A highly significant difference between BCC subtypes could be observed with regard to 
the measured optical properties. From a clinical point of view, it is more disastrous if iBCC is 
misdiagnosed as sBCC then if a sBCC is mistaken for an iBCC [5]. Hence decision criteria 
minimizing the false negative rate deserve priority. Therefore critical values could be 
determined for these optical properties permitting differentiation of sBCC from more 
aggressive BCC lesions with high area under the ROC curve and high positive likelihood 
ratio’s. 
Optical properties of sBCC with high diagnostic accuracy (>95%) and high NPV 
(>97.5%) were (i) significant lower µraf1b. and (ii) strongly increased epidermal thickness. 
These findings were the optical correlates of hemispherical grey to dark structures connected 
to the epidermis and resembling swallow nests. These are one of the morphological HD-OCT 
features diagnostic for sBCC [15]. The other typical feature is the presence of short fine holes 
spiral-shaped winded, localized around a central focus near the DEJ. The epidermis in sBCC 
was much thicker. The presence of Nod-L1 and subsequently different µraf1a and µraf1b values 
corresponded most probably to a change in size of scatterers in the swallow nests connected 
to the epidermis (see further). Compared to normal adjacent skin no significant differences 
could be found regarding the other µraf. All sBCC were located on the trunk. 
Although HD-OCT imaging missed deeper located (>570 µm) parts of the iBCC and 
nBCC, some significant differences of optical properties between these subtypes could be 
observed in comparison with normal adjacent skin. 
Optical properties of nBCC with moderate to high diagnostic accuracy (91.7% - >95.8%) 
and high NPV (93.8% - 97%) were (i) less negative µraf2 values compared to normal adjacent 
skin, and (ii) strongly decreased epidermal and papillary dermal thickness. These optical 
characteristics were in line with the morphological HD-OCT findings in nBCC [33]. These 
features are the presence of lobular structures with bright outer rim (cockade feature) located 
in the upper dermis. The roof of these lobules was observed at Z-values less than 75 µm from 
the skin surface. Moreover small branched holes are embedded in the outer bright rim. This 
explains the observed significant lesser negative µraf2 values, compared to normal adjacent 
skin. The papillary dermis in between the epidermis and lobular structures was squeezed 
resulting in strongly decreased papillary dermal thickness. The epidermis in nBCC was 
remarkably thin explaining the very low epidermal thickness. The µraf3a and µraf3b did not 
differ significantly from normal adjacent skin. Almost all nBCC in this study were located on 
the face. 
Regarding the optical properties of iBCC both the increase of µraf3b of >0.0051 cm−1 
compared to normal skin and the presence of peaks and falls in reticular dermis had high 
diagnostic accuracy (79.1% - 93.8%) and high NPV (93.8% - 96.8%). This was in line with 
the morphological HD-OCT findings in iBCC [33] which are lobulated structures into the 
deeper dermis. The roof of these structures is noticed at Z-values more than 150-µm from 
skin surface [33]. Large branched holes are embedded in a distorted fibrous stroma. There is 
a pronounced distortion of fibrous structures aligned in one direction and localized in 
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between the lobules (stretching effect). These explained the significantly higher µraf3b 
compared to normal adjacent skin and the presence of supplementary P&F-L3; peaks 
(increased NIR light backscattering) followed by falls (increased NIR light attenuation) 
corresponding with the grey core of the lobulated structures. The µraf3 remained high with 
depth in iBCC compared to normal skin; a finding that was absent in nBCC. These findings 
are in line with previous observations [54]. The OCT signal at DEJ and PRDJ was 
significantly increased in iBCC compared to normal adjacent skin. This was also observed in 
nBCC although the higher values in nBCC contrasted not significantly with those observed in 
adjacent normal skin. 
Optical property measurements sensitive for scattering and anisotropy factor g offer the 
best means of characterizing the micro-architecture of cells and tissues [43]. A decrease in 
µraf implies an increase in anisotropy factor g [43]. Hence, a decrease of µraf1b in sBCC 
implied an increase in size of scatterers and consequently an increase in anisotropy factor g at 
the lower epidermal levels and in the swallow nests of this subtype. High g values in layer-1b 
(> 0.9) corresponding with strong anisotropic scattering, seemed to be characteristic for 
sBCC. Forward scattering became more likely. Hence the lower epidermis became much 
more translucent compared to the other BCC subtypes. Both nBCC and iBCC are 
characterized by higher µraf1 and consequently lower g values (< 0.8), which correspond to 
more isotropic scattering. 
Table 5. Intrinsic age and skin layer related values of relative attenuation factors. 
Measurements are taken at inner site of right upper arm. 
Relative attenuation factor Pre-menopausal women Post-menopausal women 
layer1 (µm−1) 0.0098 [+/− 0.0012] 0.0375 [+/− 0.0037] 
layer2 (µm−1) −0.0138 [+/− −0.0026] −0.0197 [+/− −0.0038] 
Layer3a* (µm−1) 0.0241 [+/−0.0039] 0.0271 [+/−0.0051] 
Layer3b* (µm−1) 0.0150 [+/−0.0023] 0.0075 [+/− 0.0009] 
(*) nod in semi-log plot is present in layer 3: “3a” upper part and “3b” lower part 
Some major limitations of this study need to be mentioned. The main limitation of HD-
OCT for BCC diagnosis is the limited penetration depth. The second limitation is the 
selection bias at several levels: i) selection of the lesions for the study conditioned by the 
availability of “good quality” HD-OCT images, ii) selection of the tumor area sampled 
because lesions are usually much larger than HD-OCT field of view (1.5x1.8mm), and iii) the 
appropriate selection of the skin volume in a DICOM image for IV-OP analysis which 
requires experience with HD-OCT. These facts questions to some extent the accuracy of HD-
OCT in the hands of non-experts. The method called OCT based tissue injury mapping [55] 
could be useful for selection of regions of interest based on structural an microvascular 
information. As this study only represents a training set, further validation studies need to be 
performed. The third issue is related to transitions between the three mentioned BCC 
categories, which are not rare. In this study we deliberately focused on histological proven 
clear-cut BCC subtypes. A fourth problem is linked to potential imitators of basal cell 
carcinoma. As a first step it was decided to concentrate on BCC alone. 
In conclusion, HD-OCT seems to enable the rather unique combination of in vivo 
morphological analysis of cellular and micro-architectural structures with in vivo analysis of 
optical properties of tissue scatterers. In vivo HD-OCT analysis of optical properties permits 
BCC sub-differentiation with higher accuracy than in vivo HD-OCT analysis of morphology 
alone. The diagnostic performance of HD-OCT in BCC should be further assessed in other, 
multicenter clinical settings combining both types of analysis. 
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